Bemiparin sodium
haemodialysis) | |
ATC code | |
---|---|
Pharmacokinetic data | |
Bioavailability | 96% (estimated) |
Elimination half-life | 5–6 hours |
Identifiers | |
CAS Number | |
DrugBank | |
ChemSpider |
|
Chemical and physical data | |
Molar mass | 3600 g/mol (average) |
(what is this?) (verify) |
Bemiparin (trade names Ivor and Zibor, among others) is an
low molecular weight heparins (LMWH).[1]
Medical uses
Bemiparin is used for the prevention of
haemodialysis.[2]
Contraindications
The medication is contraindicated in patients with a history of heparin-induced thrombocytopenia with or without disseminated intravascular coagulation; acute bleeding or risk of bleeding; injury or surgery of the central nervous system, eyes or ears; severe liver or pancreas impairment; and acute or subacute bacterial endocarditis.[2]
Interactions
No interaction studies have been conducted. Drugs that are expected to increase the risk of bleeding in combination with bemiparin include other anticoagulants,
Chemistry
Like
factor Xa, reducing the risk of bleeding.[4]
References
External links
- bemiparin at the U.S. National Library of Medicine Medical Subject Headings (MeSH)